Publications by authors named "Corey A Carter"

Claim this Profile
C
Comparative study of survival among small cell lung cancer patients in the U.S. military health system and those in the surveillance, epidemiology, and end results (SEER) program.
Jie Lin, Christine Kamamia, Derek W Brown, Stephanie Shao, Katherine A McGlynn, Corey A Carter

Ann Epidemiol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGF-beta: a master immune regulator.
Christopher Larson, Bryan Oronsky, Corey A Carter, Arnold Oronsky, Susan J Knox

Expert Opin Ther Targets· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic".
Bryan Oronsky, Corey A Carter, Scott Caroen, Curtis Scribner, Arnold Oronsky

Oncoimmunology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer.
Bryan Oronsky, Tony R Reid, Christopher Larson, Scott Caroen, Mary Quinn, Corey A Carter

Future Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice.
Bryan Oronsky, Eilleen S Y Ao-Ieong, Ozlem Yalcin, Corey A Carter, Pedro Cabrales

Mol Pharm· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors.
Nitin Roper, Shaojian Gao, Tapan K Maity, A Rouf Banday, Xu Zhang, Corey A Carter

Cell Rep· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable Cancer.
Bryan Oronsky, Chris Larson, Tony R Reid, Corey A Carter

J Investig Med High Impact Case Rep· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs).
Christopher Larson, Bryan Oronsky, Gina Varner, Scott Caroen, Erica Burbano, Corey A Carter

Oncoimmunology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER Population.
Jie Lin, Christine Kamamia, Derek Brown, Stephanie Shao, Katherine A McGlynn, Corey A Carter

Cancer Epidemiol Biomarkers Prev· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells.
Bryan Oronsky, Tony R Reid, Arnold Oronsky, Scott Caroen, Corey A Carter

Oncotarget· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A Review.
Bryan Oronsky, Patrick Ma, Tony R Reid, Pedro Cabrales, Michelle Lybeck, Corey A Carter

Neoplasia· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.
Bryan Oronsky, Patrick C Ma, Daniel Morgensztern, Corey A Carter

Neoplasia· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management.
Bryan Oronsky, Scott Caroen, Arnold Oronsky, Vaughn E Dobalian, Neil Oronsky, Corey A Carter

Cancer Chemother Pharmacol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What's New in SCLC? A Review.
Bryan Oronsky, Tony R Reid, Arnold Oronsky, Corey A Carter

Neoplasia· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RRx-001 protects against cisplatin-induced toxicities.
Bryan Oronsky, Tony R Reid, Christopher Larson, Corey A Carter, Christina E Brzezniak

J Cancer Res Clin Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No patient left behind: The promise of immune priming with epigenetic agents.
Corey A Carter, Bryan T Oronsky, Joseph Roswarski, Arnold L Oronsky, Neil Oronsky

Oncoimmunology· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system.
Jie Lin, Abegail Gill, Shelia H Zahm, Corey A Carter, Craig D Shriver

Int J Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer.
Bryan Oronsky, Carolyn M Ray, Alexander I Spira, Jane B Trepel, Corey A Carter

Med Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Paraneoplastic Cushing Syndrome Presenting as Hyperglycemic Hyperosmolar Nonketotic Syndrome.
Christina E Brzezniak, Nicole Vietor, Patricia E Hogan, Bryan Oronsky, Bennett Thilagar, Corey A Carter

Case Rep Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion of Platinum-Etoposide-Resistant to Sensitive SCLC after Treatment with the Epi-Immunotherapeutic RRx-001: A Case Report.
Christina Brzezniak, Bryan Oronsky, Jan Scicinski, Scott Caroen, Pedro Cabrales, Corey A Carter

Oncol Res Treat· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recalcitrant small cell lung cancer: the argument for optimism.
Karen G Zeman, Christina E Brzezniak, Corey A Carter

J Thorac Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor.
Christina Brzezniak, Bryan Oronsky, Jane Trepel, Thomas A Summers, Pedro Cabrales, Corey A Carter

Case Rep Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior Vena Cava Syndrome in a Patient with Small-Cell Lung Cancer: A Case Report.
Christina Brzezniak, Bryan Oronsky, Corey A Carter, Bennett Thilagar, Scott Caroen

Case Rep Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials.
Bryan Oronsky, Ramasamy Paulmurugan, Kira Foygel, Jan Scicinski, Susan J Knox, Corey A Carter

Expert Opin Investig Drugs· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response.
Romi Biswas, Shaojian Gao, Constance M Cultraro, Tapan K Maity, Abhilash Venugopalan, Corey A Carter

Cold Spring Harb Mol Case Stud· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis